1-4 of 4
Jiaqing Pang
Close
Sort by
Journal Articles

Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs

Özgün Babur, Alexander R. Melrose, Jennifer M. Cunliffe, John Klimek, Jiaqing Pang, Anna-Liisa I. Sepp, Jevgenia Zilberman-Rudenko, Samuel Tassi Yunga, Tony Zheng, Iván Parra-Izquierdo, Jessica Minnier, Owen J. T. McCarty, Emek Demir, Ashok P. Reddy, Phillip A. Wilmarth, Larry L. David, Joseph E. Aslan
Journal: Blood
Blood (2020) 136 (20): 2346–2358.
https://doi.org/10.1182/blood.2020005496
Published: 2020
Includes: Supplemental data
Journal Articles

Tyrosine Kinase Inhibitors (TKIs) Targeting Syk and BTK Signaling Differentially Affect PI3K Signalosome Organization and Platelet Function

Tony Zheng, Elizabeth R Lofurno, Sarah Elgamal, Alexander R Melrose, Jiaqing Pang, Joseph J Shatzel, MD, Owen J T McCarty, PhD, Joseph Aslan, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2074.
https://doi.org/10.1182/blood-2019-129066
Published: 2019
Journal Articles

S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation

Joseph E. Aslan, Garth W. Tormoen, Cassandra P. Loren, Jiaqing Pang, Owen J. T. McCarty
Journal: Blood
Blood (2011) 118 (11): 3129–3136.
https://doi.org/10.1182/blood-2011-02-331579
Published: 2011
Includes: Supplemental data
Journal Articles

Identification of a Role for Apolipoprotein E Receptor 2 as a Platelet Receptor for Factor XI

Tara C White, Michelle A Berny, Erik I Tucker, Jiaqing Pang, David Gailani, MD, Rolf T Urbanus, MD, Philip G de Groot, PhD, András Gruber, MD, Owen JT McCarty, PhD
Journal: Blood
Blood (2008) 112 (11): 3914.
https://doi.org/10.1182/blood.V112.11.3914.3914
Published: 2008